BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 38645464)

  • 21. Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity.
    Anfray C; Mainini F; Digifico E; Maeda A; Sironi M; Erreni M; Anselmo A; Ummarino A; Gandoy S; Expósito F; Redrado M; Serrano D; Calvo A; Martens M; Bravo S; Mantovani A; Allavena P; Andón FT
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34531246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Employing Drug Delivery Strategies to Overcome Challenges Using TLR7/8 Agonists for Cancer Immunotherapy.
    Varshney D; Qiu SY; Graf TP; McHugh KJ
    AAPS J; 2021 Jun; 23(4):90. PubMed ID: 34181117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles.
    Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z
    Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microwave-Assisted Rapid Green Synthesis of Gold Nanoparticles Using Seed Extract of
    Perveen K; Husain FM; Qais FA; Khan A; Razak S; Afsar T; Alam P; Almajwal AM; Abulmeaty MMA
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 27. Tumor-Associated Macrophages in Tumor Immunity.
    Pan Y; Yu Y; Wang X; Zhang T
    Front Immunol; 2020; 11():583084. PubMed ID: 33365025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspective.
    Lan H; Zhang W; Jin K; Liu Y; Wang Z
    Drug Deliv; 2020 Dec; 27(1):1248-1262. PubMed ID: 32865029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune cells as tumor drug delivery vehicles.
    Combes F; Meyer E; Sanders NN
    J Control Release; 2020 Nov; 327():70-87. PubMed ID: 32735878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TNFα-TNFR2 signaling pathway in control of the neural stem/progenitor cell immunosuppressive effect: Different experimental approaches to assess this hypothetical mechanism behind their immunological function.
    Shamdani S; Uzan G; Naserian S
    Stem Cell Res Ther; 2020 Jul; 11(1):307. PubMed ID: 32698887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclodextrin-based delivery systems for in vivo-tested anticancer therapies.
    Santos AC; Costa D; Ferreira L; Guerra C; Pereira-Silva M; Pereira I; Peixoto D; Ferreira NR; Veiga F
    Drug Deliv Transl Res; 2021 Feb; 11(1):49-71. PubMed ID: 32441011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active transcytosis and new opportunities for cancer nanomedicine.
    Pandit S; Dutta D; Nie S
    Nat Mater; 2020 May; 19(5):478-480. PubMed ID: 32332990
    [No Abstract]   [Full Text] [Related]  

  • 33. Enhanced dissolution of poorly soluble antiviral drugs from nanoparticles of cellulose acetate based solid dispersion matrices.
    Mazumder S; Dewangan AK; Pavurala N
    Asian J Pharm Sci; 2017 Nov; 12(6):532-541. PubMed ID: 32104366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.
    Arbyn M; Weiderpass E; Bruni L; de Sanjosé S; Saraiya M; Ferlay J; Bray F
    Lancet Glob Health; 2020 Feb; 8(2):e191-e203. PubMed ID: 31812369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iron chelated melanin-like nanoparticles for tumor-associated macrophage repolarization and cancer therapy.
    Rong L; Zhang Y; Li WS; Su Z; Fadhil JI; Zhang C
    Biomaterials; 2019 Dec; 225():119515. PubMed ID: 31590119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective chemoimmunotherapy by co-delivery of doxorubicin and immune adjuvants in biodegradable nanoparticles.
    Da Silva CG; Camps MGM; Li TMWY; Zerrillo L; Löwik CW; Ossendorp F; Cruz LJ
    Theranostics; 2019; 9(22):6485-6500. PubMed ID: 31588231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticles from Cuttlefish Ink Inhibit Tumor Growth by Synergizing Immunotherapy and Photothermal Therapy.
    Deng RH; Zou MZ; Zheng D; Peng SY; Liu W; Bai XF; Chen HS; Sun Y; Zhou PH; Zhang XZ
    ACS Nano; 2019 Aug; 13(8):8618-8629. PubMed ID: 31246413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifunctional nanoplatform based on star-shaped copolymer for liver cancer targeting therapy.
    Gong X; Zheng Y; He G; Chen K; Zeng X; Chen Z
    Drug Deliv; 2019 Dec; 26(1):595-603. PubMed ID: 31195837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy.
    Rodell CB; Arlauckas SP; Cuccarese MF; Garris CS; Li R; Ahmed MS; Kohler RH; Pittet MJ; Weissleder R
    Nat Biomed Eng; 2018 Aug; 2(8):578-588. PubMed ID: 31015631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trial Watch: Toll-like receptor agonists in cancer immunotherapy.
    Smith M; García-Martínez E; Pitter MR; Fucikova J; Spisek R; Zitvogel L; Kroemer G; Galluzzi L
    Oncoimmunology; 2018; 7(12):e1526250. PubMed ID: 30524908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.